Cargando…

Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma

BACKGROUND: This paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma. METHODS: The alternative splicing events data with corresponding clinical information data of 79 ACC patients were obtained from the Cancer Genome Atlas and SpliceSeq pack...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Weiwei, Sun, Fangfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994755/
https://www.ncbi.nlm.nih.gov/pubmed/33776902
http://dx.doi.org/10.3389/fendo.2021.538364
_version_ 1783669821390454784
author Liang, Weiwei
Sun, Fangfang
author_facet Liang, Weiwei
Sun, Fangfang
author_sort Liang, Weiwei
collection PubMed
description BACKGROUND: This paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma. METHODS: The alternative splicing events data with corresponding clinical information data of 79 ACC patients were obtained from the Cancer Genome Atlas and SpliceSeq package. Prognosis-associated AS events by using univariate Cox regression analysis were selected. Gene functional enrichment analysis demonstrated the potential pathways enriched by survival-associated AS. Prognosis-related splicing events were submitted to develop moderate predictors using Lasso regression model. RESULTS: One thousand five survival-associated alternative splicing events were identified. The prognostic genes included ATXN2L, MEIS1, IKBKB, COX4I1. Functional enrichment analysis suggested that prognostic splicing events are associated with Wnt signaling pathway. A prediction model including 12 alternative splicing events was constructed by Lasso regression using train set. ROC analysis showed good performance of the prediction model in test set. Then, a nomogram integrating the clinical-pathological factors and riskscore was constructed for predicting 1‐ and 3‐year survival rate. CONCLUSION: Our data provide a comprehensive bioinformatics analysis of AS events in ACC, providing biomarkers for disease progression and a potentially rich source of novel therapeutic targets.
format Online
Article
Text
id pubmed-7994755
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79947552021-03-27 Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma Liang, Weiwei Sun, Fangfang Front Endocrinol (Lausanne) Endocrinology BACKGROUND: This paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma. METHODS: The alternative splicing events data with corresponding clinical information data of 79 ACC patients were obtained from the Cancer Genome Atlas and SpliceSeq package. Prognosis-associated AS events by using univariate Cox regression analysis were selected. Gene functional enrichment analysis demonstrated the potential pathways enriched by survival-associated AS. Prognosis-related splicing events were submitted to develop moderate predictors using Lasso regression model. RESULTS: One thousand five survival-associated alternative splicing events were identified. The prognostic genes included ATXN2L, MEIS1, IKBKB, COX4I1. Functional enrichment analysis suggested that prognostic splicing events are associated with Wnt signaling pathway. A prediction model including 12 alternative splicing events was constructed by Lasso regression using train set. ROC analysis showed good performance of the prediction model in test set. Then, a nomogram integrating the clinical-pathological factors and riskscore was constructed for predicting 1‐ and 3‐year survival rate. CONCLUSION: Our data provide a comprehensive bioinformatics analysis of AS events in ACC, providing biomarkers for disease progression and a potentially rich source of novel therapeutic targets. Frontiers Media S.A. 2021-03-12 /pmc/articles/PMC7994755/ /pubmed/33776902 http://dx.doi.org/10.3389/fendo.2021.538364 Text en Copyright © 2021 Liang and Sun http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Liang, Weiwei
Sun, Fangfang
Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_full Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_fullStr Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_full_unstemmed Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_short Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
title_sort prognostic alternative mrna splicing in adrenocortical carcinoma
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994755/
https://www.ncbi.nlm.nih.gov/pubmed/33776902
http://dx.doi.org/10.3389/fendo.2021.538364
work_keys_str_mv AT liangweiwei prognosticalternativemrnasplicinginadrenocorticalcarcinoma
AT sunfangfang prognosticalternativemrnasplicinginadrenocorticalcarcinoma